These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25544867)

  • 21. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of gut microecology on the pathogenesis and treatment of nonalcoholic fatty liver disease].
    Yuan Y; Sun ZM; Zhang Y; Liang FF; He XX
    Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):375-9. PubMed ID: 27470892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
    Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
    Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats].
    Chen LL; Deng XQ; Li NX
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1434-7. PubMed ID: 17785073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats.
    Deng XQ; Chen LL; Li NX
    Liver Int; 2007 Jun; 27(5):708-15. PubMed ID: 17498258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
    Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
    Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
    Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
    BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipose tissue-derived stem cells promote the reversion of non-alcoholic fatty liver disease: An in vivo study.
    Liao N; Pan F; Wang Y; Zheng Y; Xu B; Chen W; Gao Y; Cai Z; Liu X; Liu J
    Int J Mol Med; 2016 May; 37(5):1389-96. PubMed ID: 26986083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
    Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J
    Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
    Jiang Y; Chen L; Wang H; Narisi B; Chen B
    J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
    Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental study on intervention effect of Grifola frondosa on nonalcoholic steatohepatitis].
    Dai XW; Chen ZY; Yan MX; He BH
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(9):1808-11. PubMed ID: 26323153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
    Wang Y; Li JY; Han M; Wang WL; Li YZ
    Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis.
    Xu F; Li Z; Zheng X; Liu H; Liang H; Xu H; Chen Z; Zeng K; Weng J
    Diabetes; 2014 Nov; 63(11):3637-46. PubMed ID: 24947350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.